Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease.

Digestive diseases and sciences - 1 Nov 2001

Schulte C, Goebell H, Röher H D, Schulte K M

Abstract excerpt

Bone loss in inflammatory bowel disease (IBD) is presumed to be mediated by inflammation. Increased levels of the multifunctional cytokine IL-6 in inflammatory diseases have been proposed to be the link in such "inflammation-mediated osteopenia." A recently described G/C polymorphism with an effect on transcription rate and plasma levels of IL-6 suggests a genetically determined difference in the degree of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone and Bones
Share to Bone Density
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Inflammatory Bowel Diseases

Share to Interleukin-6

Share to Osteoporosis

Share to Time Factors

Source

Identifiers

PMID: 11713964
DOI: 10.1023/a:1012300609279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease.PMID 11713964Read ↗

Genetic factors determine extent of bone loss in inflammatory bowel disease.Semantic proximity Read ↗

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.Semantic proximity Read ↗

The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease.Semantic proximity Read ↗

LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease.Semantic proximity Read ↗

Is interleukin-6 important in inflammatory bowel disease?Semantic proximity Read ↗

The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.Semantic proximity Read ↗

Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.Semantic proximity Read ↗

Influence of interleukin 1alpha (IL-1alpha), IL-4, and IL-6 polymorphisms on genetic susceptibility to chronic osteomyelitis.Semantic proximity Read ↗

Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.Semantic proximity Read ↗

The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.Semantic proximity Read ↗

Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis.Semantic proximity Read ↗

Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.